Close

News

STIRA PHARMACEUTICALS LLC Certified By the Women’s Business Enterprise National Council

14 March 2026 | FAIRFIELD, NJ



STIRA PHARMACEUTICALS LLC Certified By the Women’s Business Enterprise National Council –
 

FAIRFIELD, NJ—March/12/2026— Stira Pharmaceuticals LLC, a business specializing in sterile injectables manufacturing and advanced analytical testing, is proud to announce its national certification as a Women’s Business Enterprise (WBE) by the Women’s Business Enterprise Council Metro NY, a regional certifying partner of the Women’s Business Enterprise National Council (WBENC). WBENC Certification is widely recognized as the gold standard for women-owned business certification in the United States.

“Achieving WBENC Certification is an important milestone for Stira Pharmaceuticals,” said Sandhya Kantamaneni, President. “It reflects our commitment to excellence, innovation, and leadership in the pharmaceutical industry, while also strengthening our ability to connect with organizations that value supplier diversity. As a women-owned business, this certification is meaningful not only for our company, but also for the broader community of women entrepreneurs working to create opportunity, drive innovation, and build a more inclusive economy.”

The WBENC certification standard, implemented by the Women’s Business Enterprise Council Metro NY, is a rigorous process that includes an in-depth review of the business and a site inspection. The certification process is designed to confirm that the business is at least 51% owned, operated, and controlled by one or more women, and that it has the appropriate structure, strategic planning, and operational oversight in place.

By including women-owned businesses among their suppliers, corporations and government agencies demonstrate their commitment to fostering diversity and strengthening their supplier diversity programs. In turn, this helps empower women as leaders and contributes to a more diverse, balanced, and sustainable economy.

WBENC Certification, combined with professional development and engagement within the WBENC network, provides year-round opportunities — both virtual and in-person — for women-owned businesses to grow, expand, and innovate through events, programming, and connections with major corporations and other WBEs.

To learn more about Stira Pharmaceuticals LLC, please visit www.stirapharma.com.

About Stira Pharmaceuticals LLC
Stira Pharmaceuticals LLC, founded in 2019, is a sterile injectable CDMO with integrated analytical capabilities and extensive pharmaceutical product development experience. Our team of experienced scientists develops and supports the commercialization of complex injectable products using in-house technologies, established processes, and deep technical expertise.

Flagship Capabilities:

  • Comprehensive contract analytical services
  • Analytical R&D and end-to-end product development for small molecules, peptides, oligonucleotides, and large molecules, including biosimilars
  • Three injectable robotic fill-and-finish lines using RTU components
  • Diverse sterile injectable formats, including vials, syringes, IV bags, and cartridges
  • In-house stability program, analytical laboratories, and robust regulatory support

 

About WBENC:
Founded in 1997, WBENC is the nation’s leader in women’s business development and the leading third-party certifier of businesses owned and operated by women, with more than 18,000 certified Women’s Business Enterprises, 14 national Regional Partner Organizations, and more than 500 Corporate Members, most of which are Fortune 500. Thousands of corporations representing America’s most prestigious brands, as well as many states, cities, and other entities, look for and accept WBENC Certification. Through the Women Owned initiative, WBENC also is a leader in supporting consumer-oriented female entrepreneurs and those who do business with them by raising awareness for why, where and how to buy Women Owned. For more information, visit www.wbenc.org and www.buywomenowned.com.